These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2471287)

  • 1. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results.
    Fraedrich G; Weber C; Bernard C; Hettwer A; Schlosser V
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):89-91. PubMed ID: 2471287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application--clinical experience in 152 cardiac surgical patients.
    Dietrich W; Barankay A; Dilthey G; Henze R; Niekau E; Sebening F; Richter JA
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):92-8. PubMed ID: 2471288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can administration of trasylol in reduced Hammersmith dosage with simultaneous transfusion of autologous blood meet the requirements of open heart surgery?].
    Gschossmann J; Prackl P; Siedlecki J; Binder W; Behr W; Eckart J; Struck E
    Helv Chir Acta; 1993 Dec; 60(3):427-33. PubMed ID: 7509784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
    Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
    Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of aprotinin in different doses and autologous blood transfusions in cardiac surgery.
    Gschossmann J; Pracki P; Struck E
    Cardiovasc Surg; 1994 Dec; 2(6):716-9. PubMed ID: 7532087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of low doses of aprotinin in heart surgery].
    Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J
    Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of "low dose" aprotinin in open heart surgery and its plasma concentration].
    Nakamura T; Shimamoto M; Yamazaki F; Fujita S; Yoshimura T; Ueno T; Oyanagi H; Shinozaki T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Feb; 42(2):188-93. PubMed ID: 7511150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G; Sartipy U; Ivert T; van der Linden J
    Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
    Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
    Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
    Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
    Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.